top of page

Summary

1. FDA Guidance on Hemp Product Development
-
In September of 2018, the FDA approved Epidiolex (Cannabidiol) Primer, the first plant-derived, purified pharmaceutical-grade cannabidiol (CBD) medication to treat Dravet syndrome or Lennox-Gastaut syndrome.
-
In February of 2020, FDA issued an opinion to encourage cannabis companies' development of cannabis products into prescription drugs through botanical drug development guidance for industry.
-
In Jan 2023, the FDA published "Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research Guidance for Industry."

FDA Opinion
Cannaibs Testing
FAQ
bottom of page